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Abstract
Background: Restoration of functional distance and near vision independently of additional correction
remains a goal for cataract surgery. ReSTOR®, a new multi-focal intraocular lens (IOL) addresses this issue
with an improvement in both distance and near vision, often without need for glasses. This analysis
attempted to discuss the patient-reported benefit of ReSTOR® using a full but organised representation
of data.
Methods: Two non-randomised, open-label clinical trials conducted in Europe and the United-States
were conducted to compare the efficacy of ReSTOR® to AcrySof® mono-focal IOLs. A total of 710 patients
in need of bilateral cataract extraction were included in the pooled study. The TyPE, a patient
questionnaire, was fully completed by 672 of them before and after each eye surgery. The TyPE, composed
of 67 items measuring overall visual functioning in both conditions (with and without wearing glasses),
evaluates limitations, troubles and satisfaction in distance and near vision. A principal component analysis
(PCA) of the TyPE questionnaire was performed on pooled data from baseline and post-surgery
observations in order to fully represent the change in the TyPE data over time. ReSTOR® and mono-focal
groups were used as illustrative variables. The coordinates of the first 2 factors were compared between
visits and between IOLs (ReSTOR® vs. mono-focal), using paired t-tests and t-tests, respectively.
Results: The first factor of the PCA explained 55% of the variance and represented 'visual functioning and
patient satisfaction'. The second factor explained 6% of the variance and was interpreted as 'independence
from glasses'. An overall difference in factorial coordinates in both factors was seen between baseline and
the first eye surgery, and between the first and the second eye surgery. No difference between ReSTOR®
and mono-focal IOL groups was observed at baseline. After surgery, ReSTOR® treated-patients had higher
coordinates on both "visual functioning and satisfaction" and "independence from glasses" factors. Findings
observed on the factorial plan were supported by statistical comparisons of factorial coordinates.
Conclusion: Both mono-focal and ReSTOR®-implanted patients improved their visual functioning after
bilateral cataract surgery. Moreover, ReSTOR® patients reported an additional benefit in independence
from glasses as well as in visual functioning and patient satisfaction.
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Background
Cataracts are a clouding of the lens or its surrounding
transparent membrane, characterised by a forward light
scatter, and therefore stops it from focusing on the retina
[1]. Most cataract cases are age-related and may occur in
both eyes in a long term perspective. This results in
blurred vision and visual disturbances including difficulty
in night vision, halos and sensitivity to glare. In 1994, an
estimated 38 million people were blind worldwide; 40%
of the cases were due to cataracts [2].
There is no effective prevention for cataract today and the
only way to treat it is to remove the clouded lens. Most of
the time, cataract surgery is performed using phaco-emul-
sification through a small surgical incision in the Western
developed countries [1,3]. The natural lens is then
replaced with an artificial intraocular lens (IOL).
Mono-focal IOLs allow either distance or near vision to be
corrected, while the other vision has to be corrected by
wearing glasses. Trial patients receiving the mono-focal
IOL usually chose distance correction and rely on eye-
glasses for other distances. To mimic the ability of the nat-
ural crystalline lens to focus on near objects, multi-focal
IOLs were developed. Multi-focal IOLs provide vision
over a range of distances through the provision of two pri-
mary lens powers, one power used for distance vision and
the other one for near vision. Implantation of multi-focal
IOLs after cataract surgery was reported to restore both
distance and near vision of patients and to provide them
the ability to be free of glasses [4-12].
The AcrySof® ReSTOR® multi-focal IOL is a biconvex single
piece and consists of a high refractive index soft acrylic
material. Its anterior surface is made of apodized, diffrac-
tive concentric rings in the central area distributing the
light for a full range of vision [13]. The ReSTOR® lens can
be folded prior to insertion allowing placement through
an incision smaller than the optic diameter of the lens.
The efficacy and safety of ReSTOR® has been reported by
numerous papers [14-18].
A number of studies have demonstrated the importance of
the patient-reported measures in clinical trials [19]. The
TyPE questionnaire, a validated 67-item questionnaire
measuring visual functioning relative to multi-focality [5],
showed that ReSTOR® was able to significantly improve
near vision without glasses after cataract surgery, com-
pared to AcrySof® mono-focal IOLs, allowing the majority
of ReSTOR®-implanted patients to be free of glasses
[15,16]. In contrast with previous studies which used
dimension scores of the TyPE questionnaire, the objective
of the present study was to fully present the change in
patient-reported visual functioning after cataract surgery
using the information available in all the individual items
of the TyPE questionnaire. This was undertaken using a
Principal Component Analysis (PCA) which allows the
large amount of data provided by the TyPE questionnaire
to be summarised, and thus the main information to be
extracted and interpreted. The goal of this analysis was not
to psychometrically validate new scores for the TyPE ques-
tionnaire, but to provide an alternative way of analysing
the richness of the TyPE data with a full but organised rep-
resentation of its items, and thus to confirm the superior-
ity of ReSTOR® in terms of patient-reported vision benefit.
Methods
Institutional review board or corresponding ethics com-
mittee approvals were obtained for all trials contributing
to the current analysis. Written informed consent was
obtained and studies conducted. The research followed
the tenets of the declaration of Helsinki.
This study reports results from 2 multi-centre open-label
non-randomized clinical trials [15,16]. These trials evalu-
ated the safety and efficacy of the new AcrySof® ReSTOR®
multi-focal IOL (model MA60D3) compared to the
AcrySof® mono-focal IOL (model MA60BM). The similar
design of both trials allowed data to be pooled. A total of
710 patients aged 21 and over and in need of cataract sur-
gery were bilaterally implanted with ReSTOR® or mono-
focal IOLs after phacoemulsification. All patients
included in the study signed an informed consent form.
The eye diagnosed with the most advanced cataract was
implanted first. The decision to proceed with bilateral
implantation was made by the subject and the investiga-
tor, based on the results of the visit following the first sur-
gery (30–60 days). The second implantation was carried
out within 90 days of the first one.
The 67-item TyPE questionnaire was completed before
and after cataract surgery by patients enrolled in the two
multi-centre clinical trials. The TyPE questionnaire was
developed as an endpoint to measure visual functioning
relative to multi-focality [5,6]. This instrument was
administered during this study to rate the patient-reported
visual functioning after ReSTOR® and mono-focal implan-
tation following cataract surgery.
The TyPE questionnaire is described in Table 1. It is com-
posed of 67 items organised into 4 sections: section I is
related to the frequency of wearing glasses (3 items); sec-
tion II is related to vision without correction with glasses
(30 items about limitations and satisfaction in near and
distance vision at night and during the day without
glasses); section III is related to vision with correction
with glasses (the same 30 items as section II are asked but
with glasses); section IV asks global questions (4 itemsHealth and Quality of Life Outcomes 2008, 6:10 http://www.hqlo.com/content/6/1/10
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about 'willingness to pay' and 'recent health and happi-
ness').
The TyPE items were analysed using PCA, a factorial anal-
ysis that reduces the dimensionality of a large number of
interrelated variables, while retaining as much as possible
the variation present in the data set. The large number of
variables is reduced to a conceptually more coherent set of
variables, called factors. We focussed on the 60 items of
the TyPE which measured patients' visual functioning and
their resulting satisfaction with vision. Items 4 to 63 were
analysed as active variables of PCA, whereas items 1 to 3
(which are not related to visual functioning or satisfaction
but to frequency of wearing glasses) were used as illustra-
tive variables to identify patient sub-groups. Items 64 to
67, measuring different concepts ('willingness to pay' and
'recent health and happiness'), were also used as illustra-
tive but not reported here because they were not consid-
ered useful for the purposes of this analysis. This analysis
was carried out on the overall population with the 3 time
points (one before and two after surgery) pooled together.
PCA is defined as an orthogonal linear transformation
that transforms the data to a new coordinate system such
Table 1: Description of the TyPE questionnaire
Sections Items # of items Range of scale and answer choices
Section I: Frequency of 
wearing glasses
Frequency of wearing glasses 1 from 1 "always" to 3 "never"
Frequency of wearing glasses for distance 
tasks
1 from 0 "none of the time" to 4 "all of the time"
Frequency of wearing glasses for distance and 
near tasks
1 from 0 "none of the time" to 4 "all of the time"
Section II: Vision without 
glasses
Self-reported rating of vision without glasses 1 from 1 "the worst" to 10 "the best"
Trouble with vision during the day without 
glasses
1 from 0 "no trouble at all" to 4 "major or 
overwhelming trouble"
Trouble with vision at night without glasses 1 from 0 "no trouble at all" to 4 "major or 
overwhelming trouble"
Satisfaction with overall vision without 
glasses
1 from 0 "not at all satisfied" to 4 "completely 
satisfied"
Satisfaction with vision during the day 
without glasses
1 from 0 "not at all satisfied" to 4 "completely 
satisfied"
Satisfaction with vision at night without 
glasses
1 from 0 "not at all satisfied" to 4 "completely 
satisfied"
Effect of bright light without glasses 1 from 0 "it makes it much better" to 4 "it makes 
it much worse"
Trouble with glare and halo without glasses 6 from 0 "no trouble at all" to 4 "major or 
overwhelming trouble"
Limitations in distance vision without glasses 7 from 0 "no limitation" to 4 "extreme limitation"
Limitations in near vision without glasses 5 from 0 "no limitation" to 4 "extreme limitation"
Limitations in social activities without glasses 5 from 0 "no limitation" to 4 "extreme limitation"
Section III: Vision with glasses Self-reported rating of vision with glasses 1 from 1 "the worst" to 10 "the best"
Trouble with vision during the day with 
glasses
1 from 0 "no trouble at all" to 4 "major or 
overwhelming trouble"
Trouble with vision at night with glasses 1 from 0 "no trouble at all" to 4 "major or 
overwhelming trouble"
Satisfaction with overall vision with glasses 1 from 0 "not at all satisfied" to 4 "completely 
satisfied"
Satisfaction with vision during the day with 
glasses
1 from 0 "not at all satisfied" to 4 "completely 
satisfied"
Satisfaction with vision at night with glasses 1 from 0 "not at all satisfied" to 4 "completely 
satisfied"
Effect of bright light with glasses 1 from 0 "it makes it much better" to 4 "it makes 
it much worse"
Trouble with glare and halo with glasses 6 from 0 "no trouble at all" to 4 "major or 
overwhelming trouble"
Limitations in distance vision with glasses 7 from 0 "no limitation" to 4 "extreme limitation"
Limitations in near vision with glasses 5 from 0 "no limitation" to 4 "extreme limitation"
Limitations in social activities with glasses 5 from 0 "no limitation" to 4 "extreme limitation"
Section IV: Global questions Willingness to pay 2 from 1 "nothing" to 6 "more than five dollars"
Recent health and happiness 2 from 1 "the worst" to 10 "the best"Health and Quality of Life Outcomes 2008, 6:10 http://www.hqlo.com/content/6/1/10
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that the greatest variance by any projection of the data
comes to lie on the first coordinate (called the first princi-
pal factor), the second greatest variance on the second
coordinate, and so on. The items contributing to the first
2 factors were described using a correlation circle repre-
sentation. We used the patient coordinates, after rotation,
projected on axis 1 and 2, and we calculated average per
type of IOL, to compare the impact on vision of each IOL
using all the items reported in the TyPE, without any a pri-
ori knowledge. Paired t-tests and t-tests were used to com-
pare the factorial coordinates but this should be
considered as a multivariate descriptive analysis. In addi-
tion, the distribution of the factorial coordinates was
depicted per type of IOL by showing the percentages of
patients bilaterally implanted at or above factorial 1 and
2 coordinates. The aim of this study was to describe the
overall pattern of results rather than test the statistical sig-
nificance of differences. Because of this, no adjustments
were used for multiplicity of tests. Where specific signifi-
cance tests were used, the threshold for statistical signifi-
cance was p < 0.05 for each test, with all tests interpreted
two sided. The statistical analysis was conducted with the
SAS software (SAS Institute; NC), release 9.2, and SPAD
software V6.5.
Results
Description of the pooled population at baseline
Among the patients included in the clinical trials, 672
patients fully completed the TyPE questionnaire at base-
line (pre-operation), 30–60 days after the 1st eye surgery
and 120–180 days after the 2nd eye surgery. Out of the 672
patients, 499 received ReSTOR® multi-focal IOLs and 173
were implanted with AcrySof® mono-focal IOLs.
Among the 672 patients of the studied population, 34%
were male (Table 2). The mean age of the patients was 69
years, with the ReSTOR®-implanted patients being statisti-
cally younger than the mono-focal-implanted patients
(68.9 versus 70.5 years, with p = 0.02). Before surgery, the
mean corrected distance-visual acuity (VA) of the whole
population was poor and no difference was seen between
ReSTOR® and mono-focal patients (0.39 and 0.50 logMAR
units for "distance best corrected VA" and "near chart pho-
topic distance corrected VA at best distance", respectively
(Table 2).
Correlation circle of the PCA
The 2 first factors resulting from the PCA accounted for
55% and 6% of the total variance, respectively. As the first
factor explained the majority of the variance, this showed
that the data are almost uni-dimensional, i.e. many items
tend to consistently measure a common underlying con-
cept.
A correlation circle representation of the PCA active varia-
bles (TyPE items 4 to 63) was drawn to show the items
contributing to factors 1 and 2 (Figure 1). This figure is a
simple way to represent the 60 by 60 correlation matrix of
the TyPE items. Variables close together have a positive
correlation, variables in the opposite direction are nega-
tively correlated, and orthogonal variables are independ-
ent of each other.
On the horizontal axis, the 1st factor is negatively corre-
lated with visual limitation and visual trouble items and pos-
itively with satisfaction items. This shows that the more
visually limited the patients, the less satisfied with their
vision they are. Inversely, the most satisfied patients are
also those who are the least limited. Therefore, these items
contribute to define the 1st factor as "visual functioning
and patient satisfaction". On the vertical axis the 2nd factor
was interpreted to be "independence from glasses." Vari-
ous difficulties with glasses, vision satisfaction without
glasses, and higher ratings of vision without glasses posi-
tively correlate with the idea of being independent of
glasses. Conversely, difficulties without glasses, vision sat-
isfaction with glasses, and better rating of vision with
glasses would reflect more dependence on glasses, i.e. less
independence.
Factorial plan of the PCA
The factorial plan presented in Figure 2 corresponds to the
projection of all patient coordinates according to factors 1
and 2 axes. Most of the variance can be seen on the hori-
zontal axis (55% explained), reflecting the improvement
of the whole population in "visual functioning and
patient satisfaction" after the 1st eye and after the 2nd eye
surgery. Factor 1 showed a difference in factorial coordi-
nates between baseline and after the 1st eye surgery, and a
difference between the 1st and 2nd eye surgeries, indicating
that the cataract surgery increased the visual functioning
and satisfaction of patients as soon as the 1st eye was oper-
Table 2: Demographic and visual acuity characteristics of the pooled population at baseline (N = 672)
Male n (%) 229 (34)
Age (years) Mean ± SD 69.1 ± 9.2
Distance best corrected VA at BL Mean ± SD (logMAR units) 0.39 ± 0.21
Near chart photopic distance corrected VA at best distance at BL Mean ± SD (logMAR units) 0.50 ± 0.26
BL: baseline; VA: visual acuity. Scores range from -0.3 (bad vision) to +1.0 (excellent vision) logMAR units.Health and Quality of Life Outcomes 2008, 6:10 http://www.hqlo.com/content/6/1/10
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ated on, and that another improvement was seen when
both eyes were operated on. The 2nd  most important
source of variance, represented on the vertical axis, corre-
sponds to "independence from glasses". Even though this
axis explains only 6% of the variance of the TyPE data, the
information extracted by this axis is independent from the
one extracted by the first axis and therefore discloses new
data. The projection of the 3 illustrative variables of fre-
quency of wearing glasses (empty squares) on the 1st fac-
torial plan showed that the improvement of the visual
functioning was related to a decrease in frequency of wear-
ing glasses (Figure 2). On Figure 2, black squares corre-
spond to the projection of the treatment groups at
baseline, after the 1st and after the 2nd surgery on the fac-
torial plan. They illustrate the overall difference in the fac-
torial coordinates on the "visual functioning and
satisfaction" factor, indicating an improvement in both
treatment groups after the 1st eye surgery and after the 2nd
eye surgery, with the ReSTOR® group tending to show a
larger improvement compared to the mono-focal group.
The projection of the treatment groups on the second fac-
tor axis showed a difference in their factorial coordinates
between baseline and the 1st eye surgery, indicating that
both groups tended to stop wearing glasses after the 1st eye
surgery. After the 2nd  eye surgery, ReSTOR®  patients
remained free from glasses whereas the mono-focal
patients again became dependent on glasses.
In order to quantify these results, factorial coordinates of
the pooled population were compared between visits
using statistical tests (Table 3). Significant improvements
from baseline were observed on both factor axes after the
1st and after the 2nd eye surgery, as well as when comparing
the improvement from the 1st to the 2nd eye surgery (all p
values < 0.0001).
Differences between ReSTOR®  and mono-focal groups
were shown by comparison of their factorial coordinates.
At baseline, ReSTOR® and mono-focal coordinates were
equivalent on the 1st and the 2nd factor axes (p = 0.2451
and p = 0.2647, respectively). After the 1st eye surgery, a
great shift was observed on the 1st factor axis in both ReS-
Correlation circle representation of the PCA active variables (TyPE items 4 to 63) considering factors 1 and 2 Figure 1
Correlation circle representation of the PCA active variables (TyPE items 4 to 63) considering factors 1 and 2.
Factor 2: Independence from glasses (6%)
Factor 1: Visual functioning and patient satisfaction (55%)
Factor 2: Independence from glasses (6%)
Factor 1: Visual functioning and patient satisfaction (55%)
Factor 2: Independence from glasses (6%)
Factor 1: Visual functioning and patient satisfaction (55%)
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TOR® and mono-focal groups indicating an improvement
in "visual functioning and patient satisfaction" in both
groups (Table 3). However, ReSTOR® patients had signifi-
cantly higher coordinates than mono-focal patients,
meaning that ReSTOR® patients improvement was better
than the mono-focal group (p = 0.0166). This difference
in "visual functioning and patient satisfaction" between
ReSTOR® and mono-focal patients' coordinates was con-
firmed after the 2nd eye surgery (p = 0.0067). On the 2nd
factor axis, patients bilaterally implanted with ReSTOR®
Location of patients scores in the factorial plan composed by factors 1 and 2 Figure 2
Location of patients scores in the factorial plan composed by factors 1 and 2. Grey dots correspond to assessment 
at baseline (BL), yellow dots to assessment after the 1st eye surgery (EYE1) and orange dots to assessment after the 2nd eye 
surgery (EYE2).
Factor 2: Independence from glasses (6%)
Factor 1: Visual functioning and patient satisfaction (55%)
Improvement Deterioration
High 
independence
High 
dependence
Frequency of wearing glasses
Frequency of wearing glasses for distance tasks
Frequency of wearing glasses for near tasks
Factor 2: Independence from glasses (6%)
Factor 1: Visual functioning and patient satisfaction (55%)
Improvement Deterioration
High 
independence
High 
dependence
Factor 2: Independence from glasses (6%)
Factor 1: Visual functioning and patient satisfaction (55%)
Improvement Deterioration
High 
independence
High 
dependence
Frequency of wearing glasses
Frequency of wearing glasses for distance tasks
Frequency of wearing glasses for near tasks
 
Table 3: Factorial coordinates of ReSTOR® and mono-focal mean scores considering factors 1 and 2
Mono-focal (N = 173) Mean ± SD ReSTOR® (N = 499) Mean ± SD p values†
Factor 1: Visual functioning and 
patient satisfaction
At baseline 5.91 ± 5.15 5.39 ± 4.52 0.2451
After 1st eye surgery -0.51 ± 4.56 -1.41 ± 4.14 0.0166
After 2nd eye surgery -3.86 ± 2.63 -4.52 ± 2.78 0.0067
Factor 2: Independence from 
glasses
At baseline -0.50 ± 2.53 -0.74 ± 2.41 0.2647
After 1st eye surgery 0.22 ± 2.03 0.54 ± 1.73 0.0646
After 2nd eye surgery -0.52 ± 1.53 0.47 ± 0.86 <0.0001
† p values correspond to t-tests.Health and Quality of Life Outcomes 2008, 6:10 http://www.hqlo.com/content/6/1/10
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had also higher coordinates than mono-focal patients
after the 2nd eye surgery (p < 0.0001).
The factorial scores were also represented on Figures 3 and
4 that depict the decumulative percentage of bilaterally
implanted patients at or above factorial coordinates on
factors 1 (Fig. 3) and 2 (Fig. 4). It shows that "Visual func-
tioning and satisfaction" of the ReSTOR® patients was
never less than that of monofocal IOL patients and that a
difference is noticeable in 80% of the population bilater-
ally implanted (Figure 3). The results concerning "Glasses
independence" were even stronger with a very clear differ-
ence between the two curves supporting a better outcome
of ReSTOR® (Figure 4).
Discussion
The objective of this study was to quantify vision benefit
following cataract surgery as reported by the patients. A
large number of patients in need of cataract surgery and
enrolled in 2 multi-centre clinical trials were bilaterally
implanted with either AcrySof® ReSTOR®, or a mono-focal
control IOL. To assess patient-reported visual functioning,
patients filled in the 67-item TyPE questionnaire before
cataract surgery, after the 1st and after the 2nd eye surgery.
The multiplicity constituting the patient's perspective is
reflected by the high number of items in the TyPE ques-
tionnaire. Because pre-specification was not possible in
this post-hoc analysis, we chose to analyse TyPE data
obtained before surgery, after the 1st and after the 2nd eye
surgery using PCA. The PCA was carried out on the overall
population with the 3 TyPE assessments being analysed
together. The analysis taking into account the 3 time
points enables dynamic interpretation of visual function-
ing evolution. Indeed PCA is a powerful method to organ-
ise multiple variables that are more or less correlated, and
thus reveals new meaningful information. Moreover PCA
does not need rigorous distributional assumptions such
as normality when it is used as a descriptive tool [20]. This
is why PCA is an appealing method to deal with multiplic-
ity issues [21].
Our work did not explore new scoring methods based on
classical or modern psychometric theory, such as Rasch
Analysis. Revisiting the scoring algorithm of the TyPE
could be interesting but goes beyond the scope of our
work. Indeed, the original contribution of PCA is that the
overall information is summarised and organised without
assumptions about the conceptual content of the scale. As
TyPE scores were constructed on clinical arguments, it was
important to analyse results without assumptions con-
cerning item correlations. The benefit of this method was
to reveal two meaningful independent domains of
improvement for the patients. The main factor revealed by
the PCA was interpreted as "visual functioning and
patient satisfaction". This 1st factor accounted for more
than half the total variance (55%). The 2nd discriminant
factor of change (6% of the total variance) resulting from
the PCA was defined as "independence from glasses". This
2nd factor opposes "with glasses" and "without glasses"
items. Beyond the confirmation of the benefit of cataract
surgery on visual functioning and patient satisfaction, a
second interesting direction of improvement independ-
ently reported by patients is the free from glasses vision.
Despite a structure which the PCA reveals as strongly uni-
dimensional, it is noticeable that the second source of var-
Visual functioning and satisfaction after the 2nd eye surgery Figure 3
Visual functioning and satisfaction after the 2nd eye surgery. Percentages of patients (x axis) who have factorial 1 coor-
dinates at or above values on the y axis, i.e. 80% of patients of mono-focal and ReSTOR® treatment groups have a factorial 
coordinate ≥ 2.5 (N= 499 for ReSTOR and N= 173 for mono-focal).
0
20
40
60
80
100
- 8 - 7 - 6 - 5 - 4 - 3 - 2 - 1012345678
Mono-focal
(N=173)
ReSTOR
(N=499)
Low High
Factor 1 after 2nd eye surgery
(Visual functioning and satisfaction)Health and Quality of Life Outcomes 2008, 6:10 http://www.hqlo.com/content/6/1/10
Page 8 of 9
(page number not for citation purposes)
iance in our dataset can so easily be interpreted. The PCA
results demonstrated that ReSTOR®  and mono-focal
patients reported improvement in "visual functioning and
satisfaction". However, the visual functioning improve-
ment perceived by ReSTOR® patients was higher than the
one with mono-focal IOLs. Moreover, the independence
from glasses already reported by multi-focal implanted-
patients [4-6,8-10,12] was higher with ReSTOR® than with
mono-focal IOLs after the 2nd eye surgery. Indeed, both
groups of patients tended to stop wearing glasses after the
1st surgery probably because of the bother caused by their
glasses correcting one eye only. ReSTOR®-implanted
patients were still free from glasses when both eyes were
operated, while mono-focal implanted patients were
again dependent from glasses after the 2nd eye is operated.
According to the theoretical model of Oliver, patients' sat-
isfaction results from the comparison between their initial
expectations and the performance they eventually per-
ceive from their treatment [22]. As a result, the higher
expectations are, the more difficult it is to satisfy them. As
the decision to be bilaterally implanted with ReSTOR® was
made by the patients themselves, they had a high level of
expectations. In this context, the high level of independ-
ence from glasses reported by patients with bilateral
implantation of ReSTOR® supported the value of ReSTOR®
on near vision without glasses.
A prospective randomised study previously carried out
with patients in need of cataract surgery showed that 60%
of them reported discomfort when using glasses for near
vision [8]. After cataract surgery, the multi-focal
implanted-patients of this study reported a higher level of
satisfaction with their near vision than the mono-focal
implanted-patients [8]. ReSTOR® results are in accordance
with these data; ReSTOR® patients were more satisfied and
more easily performed activities requiring near vision
without glasses than mono-focal patients [15,16,18]. It
should be noticed that Acrysof was chosen since it shares
the same platform as Acrysof ReSTOR®, therefore mini-
mising the factors that could confound the comparisons
between multi-focal and mono-focal IOLs. Consequently,
results may not be generalised to other IOLs.
It was also clearly demonstrated that improvement in
health-related quality of life (HRQoL) occurred when vis-
ual functioning improved following cataract surgery [23].
However, the present study relates only the functional
aspects of vision evaluated by the TyPE. A more complete
analysis of ReSTOR® patients' HRQoL could be under-
taken using validated questionnaires such as the 25-item
National Eye Institute Visual Function Questionnaire
(NEI-VFQ25) developed to assess the influence of visual
disability on HRQoL in patients with chronic eye diseases
or low vision [24], or the Quality of Life Impact of Refrac-
tive Correction (QIRC) questionnaire developed to quan-
tify the HRQoL of people with refractive correction by
spectacles, contact lenses or refractive surgery [25]. Evalu-
ating HRQoL aspects such as psychological, social and
emotional well-being in ReSTOR® patients would bring to
light further information.
Glasses independence after the 2nd eye surgery Figure 4
Glasses independence after the 2nd eye surgery. Percentages of patients (x axis) who have factorial 2 coordinates at or 
above values on the y axis, i.e. 50% of patients of ReSTOR® treatment groups have a factorial coordinate ≥ 0.5 (N= 499 for 
ReSTOR and N= 173 for mono-focal).
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Conclusion
In summary, these analyses showed a full but organised
description of the change in patient-reported visual func-
tioning after cataract surgery. The main factor of "visual
functioning and patient satisfaction" resulting from the
Principal Component Analysis separates baseline, 1st and
2nd eye surgery TyPE assessments. The 2nd most important
source of variance resulting from the PCA and corre-
sponding to "independence from glasses", allowed differ-
entiation between mono-focal and ReSTOR® patients after
the 2nd eye surgery. This original representation of the
TyPE data confirms that while mono-focal patients did
improve their visual functioning and satisfaction after cat-
aract surgery, ReSTOR® patients rated an additional bene-
fit in visual functioning and satisfaction as well as in
independence from glasses. The full benefit was reached
after the second surgery.
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